Indutrade makes two add-on acquisitions within Life Science
Indutrade makes two add-on acquisitions within Life Science
Indutrade has signed agreements to acquire all shares in the Danish company Dorte Egelund ApS and the Finnish company Albiox Oy, with combined annual sales of approximately SEK 60 million.
Dorte Egelund is a technical trading company specialised in microbiological and related technical solutions to the Danish market. Customers include pharmaceutical manufacturers, laboratories and food and beverage producers. Dorte Egelund was founded in 2008, has 4 employees and is located in Roskilde, Denmark.
Albiox is specialised in cleanroom products, customised solutions for drug-manufacturing, services, and biological media for pharmacies and pharmaceutical manufacturers in the Nordics. Albiox was founded in 2003, has 7 employees and is located in Helsinki, Finland.
As add-ons to Indutrade-owned Labema in Finland, the companies complement and strengthen each other. The acquired companies will continue to operate independently under the Labema Group.
Closing is expected to be completed in July and the companies will be included in Indutrade's Business Area Life Science. The acquisitions are Indutrade's eighth and ninth in 2026 and are expected to have a marginally positive impact on Indutrade's earnings per share.